Insider · CIK 0002155825
Ronnie Duane Clark
Files at INMB (Inmune Bio, Inc.). First filing -, latest -.
In brief
Ronnie Duane Clark files SEC Form 4 as director at INMB (Inmune Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ronnie Duane Clark has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | INMB Inmune Bio, Inc. | AGrant or award Stock Optionsderivative | +100,000 | $0.00 | $0 | 100,000 | 21 d ago |
Questions about Ronnie Duane Clark
Answered from the filings on this page, as of the latest one.
Is Ronnie Duane Clark buying or selling?
Ronnie Duane Clark has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ronnie Duane Clark's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronnie Duane Clark has 0.
Where does Ronnie Duane Clark file Form 4?
Ronnie Duane Clark has filed Form 4 at INMB (Inmune Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.